Biotechnology specialist Ginkgo Bioworks (NYSE:DNA) is seeing shares skyrocket today following an announcement of a potentially lucrative collaboration. Specifically, Ginkgo will partner with Syngenta, which is billed as a “leader in agricultural innovation.” Together, the two will work to launch a new biological solution. Given the underlying credibility boost, DNA stock is up around 20% as of this writing.According to a press release, Ginkgo aims to “develop and optimize” a microbial strain for a secondar ...